Complications of partial pneumonectomy
Conditions
Interventions
BP:Paravertebral block was performed with methylene blue before surgery
MN:Near intercostal block was used after operation
UP:Paravertebral block was used after operation
UN:Near intercostal block was used after operation
MP:Paravertebral block was used after operation
BN:Near intercostal block was performed with methylene blue before surgery
Sponsors
Union Hospital affiliated to Fujian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) All voluntarily signed an informed consent form before the start of anesthesia; (2) They are older than 18 years old, have an American Society of Anesthesiologists (ASA) classification of I-III, and have a body mass index (BMI) of less than 40 kg/m2 ; (3) Patients who were to undergo elective unilateral thoracoscopic partial lung resection and were first-time patients undergoing thoracoscopic radical lung cancer surgery (patients whose surgery ended before 11:00 a.m.); (4) Patients with the ability to determine pain scores.
Exclusion criteria
Exclusion criteria: (1) Psychiatric systemic illness or poor compliance to complete the experiment; (2) Acute lung infection in the last 4 weeks; (3) History of intrathoracic surgery, pneumothorax, branchial dilatation, tuberculosis, and fibrosis; (4) Patients with allergy or known history of allergy to the drugs specified in the study protocol of this project (drugs such as ropivacaine, propofol, sufentanil, rocuronium bromide, remifentanil, etc.) and their excipients; (5) Preoperative use of hormonal drugs (within 6 months); (6) Combined autoimmune disease, connective tissue disease, etc. requiring long-term treatment with adrenocorticotropic hormone; (7) Those who are addicted and resistant to opioids; (8) Intraoperative/postoperative fatal complications such as hemorrhage and anaphylactic shock; (9) Those with intermediate open-heart surgery; (10) Patients with a history of chronic pain or long-term use of opioid analgesics, general anesthetics, sedatives, hypnotics or other central nervous system depressants; (11) Patients with severe cardiac, hepatic or renal insufficiency; (12) Coagulation dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain score;Total postoperative sufentanil dosage;Time of pain relief pump for the first time after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Methylene blue diffusion gap;Percentage of area in the methylene blue spine area;The rate of methylene blue metabolism;Inflammatory index;stress index;Mean arterial pressure;Postoperative pain in the interscapular region;Incidence of postoperative nausea and vomiting;Use of postoperative remedial analgesics; | — |
Countries
China
Contacts
Public ContactZhongmeng Lai
Fujian medical university union hospital
Outcome results
None listed